From: IL-17A is increased in the serum and in spinal cord CD8 and mast cells of ALS patients
Subject | Age (at death) | Sex | Pathological Diagnosis |
---|---|---|---|
1 | 75 years | female | Sporadic amyotrophic lateral sclerosis |
2 | 83 years | male | Sporadic amyotrophic lateral sclerosis |
3 | 83 years | male | Sporadic amyotrophic lateral sclerosis |
4 | 50 years | male | Sporadic amyotrophic lateral sclerosis |
5 | 66 years | male | Sporadic amyotrophic lateral sclerosis |
6 | 64 years | female | Sporadic amyotrophic lateral sclerosis |
7 | 64 years | female | Sporadic amyotrophic lateral sclerosis |
8 | 54 years | male | Sporadic amyotrophic lateral sclerosis |
9 | 67 years | male | Alzheimer disease, Braak stage VI |
10 | 90 years | male | Braak stage VI |
11 | 76 years | male | Braak stage I |
12 | 37 years | male | Angiosarcoma of pleura, no metastases |
13 | 78 years | male | No neuropathology |
14 | 62 years | female | No neuropathology |
15 | 46 years | Male | No neuropathology |